Our research provides evidence that except anti-tumor effect, PRMT5 inhibitor may also be applied to the treatment of various diseases related to ICs, such as chronic pain, dysgeusia, disorders affecting nervous system, muscles, heart, kidneys and so on. The gene discussed is PRMT5; the disease is neoplasm.